CXCR2-mediated recruitment of adaptive NK cells with NKG2C/HLA-E dependent antigen-specific memory enhances tumor killing in ovarian cancer

Natural killer (NK) cells have emerged as promising effectors in cancer immunotherapy due to their ability to recognize and eliminate tumor cells. To investigate the immunological memory and tumor reactivity of adaptive (a)NK cells in the context of desmoplastic tumors, we used human ovarian cancer as a model. Through in vitro culture systems resembling dendritic cell (DC)-mediated T cell activation, we demonstrated that aNK cells exhibit antigen-specific cytotoxic responses and memory generation towards ovarian tumor antigens. Furthermore, mature DCs presenting tumor-associated antigens induced the expansion of aNK cells, suggesting antigen-specific proliferation. Single-cell transcriptomics revealed a distinct genetic signature of aNK cells in tumor samples, characterized by a cytotoxic phenotype and interactions with myeloid cells, particularly DCs. The spatial analysis confirmed the intratumoral presence of aNK cells, with higher abundance in the tumor nest compared to conventional (c)NK cells. Functional assays demonstrated the cytotoxicity of expanded aNK cells against autologous ovarian tumors, accompanied by an activated receptor profile. Importantly, aNK cells displayed antigen-specific memory responses towards primary tumors, maintaining specificity over time. Blockade of NKG2C and HLA-E influenced aNK cell recall responses, indicating their roles in the adaptive NK cell immune memory. Additionally, CXCR2 was essential for efficient aNK cell migration toward tumors. These findings shed light on the therapeutic potential of aNK cells in ovarian cancer immunotherapy, highlighting their ability to develop immunological memory and effectively eradicate tumor cells.